QT Imaging (QTI) Projected to Post Quarterly Earnings on Monday

QT Imaging (NASDAQ:QTI) will likely be issuing its Q3 2026 resultson Monday, November 9th. Analysts expect the company to announce earnings of ($0.0875) per share and revenue of $10.79 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:00 PM ET.

QT Imaging (NASDAQ:QTI) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). The firm had revenue of $7.44 million during the quarter, compared to analyst estimates of $7.60 million. QT Imaging had a negative net margin of 77.25% and a negative return on equity of 1,202.69%. On average, analysts expect QT Imaging to post ($1.11) EPS for the current fiscal year and $0.13 EPS for the next fiscal year.

QT Imaging Price Performance

Shares of QTI stock opened at $2.14 on Monday. The firm’s 50-day moving average is $2.60 and its 200-day moving average is $4.47. The stock has a market cap of $29.47 million, a price-to-earnings ratio of -1.36 and a beta of 0.02. The company has a debt-to-equity ratio of 6.81, a quick ratio of 2.06 and a current ratio of 3.10. QT Imaging has a 52-week low of $2.14 and a 52-week high of $7.60.

Wall Street Analyst Weigh In

QTI has been the topic of a number of research analyst reports. D. Boral Capital started coverage on QT Imaging in a research note on Friday, October 23rd. They issued a “buy” rating and a $9.00 price target on the stock. Craig Hallum assumed coverage on shares of QT Imaging in a research report on Monday, October 5th. They set a “buy” rating and a $8.00 target price on the stock. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of QT Imaging in a report on Tuesday, October 6th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, QT Imaging currently has an average rating of “Hold” and an average price target of $8.50.

About QT Imaging

QT Imaging Holdings, Inc (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation.

The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.